The Best Marijuana Merchandise on the Web
A combination of ongoing marihuana legalizations (both medical and recreational), organic growth within existing markets, and the rise of cannabidiol (CBD), the nonpsychoactive cannabinoid best known for its perceived medical benefits, are all reasons that the U.S. cannabis market continues to thrive.
Here are the 5 biggest Dispensary companies in the U.S.:
Harvest Health, whose stores operate under the "Harvest" name, which has more than 230 facility licenses on a pro forma basis (i.e., if all of its pending acquisitions were to close). Of these facilities, 142 are for retail licenses spanning 17 states.
Currently, Green Thumb has licenses to open up to 89 retail locations, with a presence in one dozen states and 23 open Rise-branded stores.
Acreage Holdings comes in third with 88 retail licenses, just one behind GTI. However, Acreage does lead all multi-state dispensary operators on the basis of state presence. It has retail licenses and an aggregate of 1.2 million square feet of production facilities or processing sites in 20 U.S. states on a pro forma basis.
Slotting in fourth but easily within striking distance for the No. 2 spot is upscale cannabis chain MedMen Enterprises, which is on a mission to normalize the cannabis-buying experience. On a pro forma basis, MedMen has licenses for 86 stores in 12 states, with 37 stores currently open.
Lastly, we have Curaleaf, the current leader among U.S. dispensaries in open locations, with 45. Operating in a dozen states, Curaleaf also has 12 cultivation sites and 11 processing facilities.
Canada-based Canopy Growth is the largest marihuana company in the world with a market capitalization of $6.03 billion. Formerly known as Tweed Marijuana, the company changed its name to Canopy Growth in
Aurora Cannabis, also based in Canada, is the world’s second-largest marihuana company with a market capitalization of $5.12 billion. It also operates as a pharmaceutical wholesaler and narcotics dealer of medical marihuana in Germany and the European Union.
Cambridge, UK-based GW Pharmaceuticals is a biopharmaceutical company and the third-largest marihuana company with a market capitalization of $4.28 billion.
Canada-based MedReleaf Corp. is ranked as the world’s fourth-largest marihuana company with a market capitalization of $2.64 billion. In May, MedReleaf agreed to be acquired by larger Canadian peer Aurora Cannabis for C$3.2 billion.
Aphria, one of Canada’s lowest cost producers of marihuana, is ranked fifth among the biggest marihuana companies with a market capitalization of $2.44 billion. The company is based in Leamington, Ontario, the greenhouse capital of Canada.
Cronos Group, a Canadian licensed producer and distributor of medical cannabis stood in sixth position among the world’s biggest marihuana companies with a stock market capitalization of $1.24 billion.
The Hydropothecary Corp. stood in seventh position among the world’s largest cannabis companies with a market capitalization of $943.54 million. It is the only licensed producer headquartered in Quebec, and also counts itself as one of
Canada’s lowest-cost producers.
Canada-based CannTrust stood in eighth position among the world’s biggest marihuana companies with a market capitalization of $846.54 million. The company’s shares recently commenced trading on the Toronto stock exchange.
OrganiGram, a Toronto Stock Exchange listed company and a licensed producer of medical marihuana in Canada, is ranked as the ninth largest marihuana company with a market capitalization of $664.26 million.
Ontario-based Auxly Cannabis, which recently changed its name from Cannabis Wheaton Income Corp., is the world’s tenth biggest marihuana company with a market capitalization of $466.11 million.l.